Processa appoints Russell Skibsted as CFO; James Stanker retires

Processa Pharmaceuticals, Inc.

Russell Skibsted appointed CFO effective July 16, 2024; succeeds James Stanker who retired.
Skibsted brings 30 years of pharma finance experience; most recently CFO of Alimera Sciences.
Annual base salary $400,000; eligible for 35% target bonus and 28,000 RSUs upon goal achievement.
Stanker remains part-time employee during transition period.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James Stanker

Chief Financial Officer

PCSA · Processa Pharmaceuticals, Inc.

Effective: 2024-07-15
Filed: July 17, 2024, 7:59 PM ET

by mutual agreement, James Stanker resigned as Chief Financial Officer of the Company, effective July 15, 2024.

Appointed

Russell Skibsted

Chief Financial Officer

PCSA · Processa Pharmaceuticals, Inc.

Effective: 2024-07-16
Filed: July 17, 2024, 7:59 PM ET

announced the appointment of Mr. Russell Skibsted, Effective July 16, 2024 as its Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Stanker resigned as Chief Financial Officer at Processa Pharmaceuticals, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

by mutual agreement, James Stanker resigned as Chief Financial Officer of the Company, effective July 15, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Russell Skibsted was appointed as Chief Financial Officer at Processa Pharmaceuticals, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

announced the appointment of Mr. Russell Skibsted, Effective July 16, 2024 as its Chief Financial Officer.

View on SEC.gov

Processa Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-028093

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.